检索结果 - Rodrigo X. Das Neves

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial 由 Diwakar Davar, Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin, F. Amatore, Julie S. Deutsch, Rodrigo X. Das Neves, Richard R. Rodrigues, John A. McCulloch, Hong Wang, Douglas J. Hartman, Jonathan H. Badger, Miriam R. Fernandes, Yulong Bai, Jie Sun, Alicia M. Cole, Poonam Aggarwal, Jennifer R. Fang, Christopher Deitrick, Riyue Bao, Umamaheswar Duvvuri, Shaum Sridharan, Seungwon Kim, Haroon A. Choudry, Matthew P. Holtzman, James F. Pingpank, James Patrick O'Toole, Richelle DeBlasio, Yang Jin, Quanquan Ding, Wentao Gao, Christopher Groetsch, Ornella Pagliano, Amy Rose, Corey Urban, Jagjit Singh, Prajan Divarkar, David Mauro, Dmitri Bobilev, James E. Wooldridge, Arthur Μ. Krieg, Matthew G. Fury, Jeffrey R. Whiteaker, Lei Zhao, Amanda G. Paulovich, Yana G. Najjar, Jason J. Luke, John M. Kirkwood, Janis M. Taube, Hyun Jung Park, Giorgio Trinchieri, Hassane M. Zarour